Feb 28 2012
In this post in Malaria Free Future's "Malaria Matters" blog, Bill Brieger, a professor in the health systems program of the Department of International Health at Johns Hopkins University, examines recent discoveries of fake malaria medications being sold in Tanzania. He writes, "All of this comes amid efforts of [the Affordable Medicines Facility malaria (AMFm)] to ensure that prequalified anti-malarial drugs reach the market (public and private) at prices people can afford. Cheap fake drugs threaten this effort." He concludes, "Despite improved access to [artemisinin-combination therapies (ACTs)] and improved quality of front line medicine store outlets, Tanzania cannot let up on its pharmacovigilence" (2/27).
 This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.
|
Breakthrough discovery could lead to novel malaria vaccines and therapies